XML 20 R9.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Financial Instruments
3 Months Ended
Mar. 31, 2024
Investments, All Other Investments [Abstract]  
Financial Instruments Financial Instruments
Cash, Cash Equivalents and Marketable Securities

The following tables summarize our cash and cash equivalents, and marketable securities on our Condensed Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023 (in thousands):
Reported as:
March 31, 2024Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair ValueCash and Cash EquivalentsMarketable securities, short-termMarketable securities, long-term
Cash$816,224 $— $— $816,224 $816,224 $— $— 
Money market funds49,581 — — 49,581 49,581 — — 
Corporate bonds26,535 (417)26,121 — 24,551 1,570 
U.S. government treasury bonds
4,871 — (101)4,770 — 2,721 2,049 
Asset-backed securities586 — (1)585 — 585 — 
U.S. government agency bonds5,264 — (20)5,244 — 5,244 — 
Total$903,061 $$(539)$902,525 $865,805 $33,101 $3,619 


Reported as:
December 31, 2023Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair ValueCash and Cash EquivalentsMarketable securities, short-termMarketable securities, long-term
Cash$887,682 $— $— $887,682 $887,682 $— $— 
Money market funds49,756 — — 49,756 49,756 — — 
Corporate bonds31,943 (676)31,272 — 28,704 2,568 
U.S. government treasury bonds
4,855 — (99)4,756 — — 4,756 
Asset-backed securities1,416 (1)1,417 — 719 698 
Municipal bonds702 — (2)700 — 700 — 
U.S. government agency bonds5,215 — (34)5,181 — 5,181 — 
Total$981,569 $$(812)$980,764 $937,438 $35,304 $8,022 

The following table summarizes the fair value of our available-for-sale marketable securities classified by contractual maturity as of March 31, 2024 and December 31, 2023 (in thousands):

March 31, 2024December 31, 2023
Due in 1 year or less $32,515 $34,617 
Due in 1 year through 5 years4,205 8,709 
Total$36,720 $43,326 
The securities that we invest in are generally deemed to be low risk based on their credit ratings from the major rating agencies. The longer the duration of these securities, the more susceptible they are to changes in market interest rates and bond yields. As interest rates increase, those securities purchased at a lower yield show a mark-to-market unrealized loss. Our unrealized losses as of March 31, 2024 and December 31, 2023 are primarily due to changes in interest rates and credit spreads.

The following tables summarize the fair value and gross unrealized losses as of March 31, 2024 and December 31, 2023, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position (in thousands):

As of March 31, 2024
Less than 12 months12 Months of GreaterTotal
March 31, 2024Fair ValueUnrealized LossFair ValueUnrealized LossFair ValueUnrealized Loss
Corporate bonds$1,006 $(3)$22,805 $(414)$23,811 $(417)
U.S. government treasury bonds
2,049 (26)2,721 (75)4,770 (101)
Asset-backed securities535 (1)— — 535 (1)
Municipal bonds— — — — — — 
U.S. government agency bonds4,051 (9)1,193 (11)5,244 (20)
Total$7,641 $(39)$26,719 $(500)$34,360 $(539)

As of December 31, 2023
Less than 12 months12 Months of GreaterTotal
December 31, 2023Fair ValueUnrealized LossFair ValueUnrealized LossFair ValueUnrealized Loss
Corporate bonds$— $— $27,939 $(676)$27,939 $(676)
U.S. government treasury bonds
2,044 (11)2,712 (88)4,756 (99)
Asset-backed securities1,018 (1)83 — 1,101 (1)
Municipal bonds— — 700 (2)700 (2)
U.S. government agency bonds4,003 (11)1,178 (23)5,181 (34)
Total$7,065 $(23)$32,612 $(789)$39,677 $(812)

Accounts Receivable Factoring

We enter into factoring transactions on a non-recourse basis with financial institutions to sell certain of our non-U.S. accounts receivable. We account for these transactions as sales of accounts receivables and include the cash proceeds as a part of our cash flows from operations in the Condensed Consolidated Statements of Cash Flows. Total accounts receivable sold under the factoring arrangements was $14.6 million during the three months ended March 31, 2024 and $8.0 million during the three months ended March 31, 2023. Factoring fees on the sales of receivables were recorded in other income (expense), net in our Condensed Consolidated Statement of Operations and were not material.

Fair Value Measurements

Fair value is an exit price, representing the amount that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We use the GAAP fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. This hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The three levels of inputs that may be used to measure fair value:

Level 1 — Quoted (unadjusted) prices in active markets for identical assets or liabilities.

Level 2 — Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability. We obtain fair values for our Level 2 investments. Our custody bank and asset managers independently use
professional pricing services to gather pricing data which may include quoted market prices for identical or comparable financial instruments, or inputs other than quoted prices that are observable either directly or indirectly, and we are ultimately responsible for these underlying estimates.

Level 3 — Unobservable inputs to the valuation methodology that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies or similar valuation techniques, as well as significant management judgment or estimation.

The following tables summarize our financial assets measured at fair value as of March 31, 2024 and December 31, 2023 (in thousands):
DescriptionBalance as of
March 31, 2024
Level 1

Level 2
Cash equivalents:
Money market funds$49,581 $49,581 $— 
Short-term investments:
U.S. government agency bonds5,244 — 5,244 
U.S. government treasury bonds2,721 — 2,721 
Corporate bonds24,551 — 24,551 
Asset-backed securities585 — 585 
Long-term investments:
U.S. government treasury bonds2,049 — 2,049 
Corporate bonds1,570 — 1,570 
$86,301 $49,581 $36,720 

DescriptionBalance as of December 31, 2023Level 1Level 2
Cash equivalents:
Money market funds$49,756 $49,756 $— 
Short-term investments:
Corporate bonds28,704 — 28,704 
Municipal bonds700 — 700 
U.S. government agency bonds
5,181 — 5,181 
Asset-backed securities719 — 719 
Long-term investments:
U.S. government treasury bonds
4,756 — 4,756 
Corporate bonds2,568 — 2,568 
Asset-backed securities
698 — 698 
$93,082 $49,756 $43,326 


Investments in Privately Held Companies

Our investments in privately held companies in which we cannot exercise significant influence and do not own a majority equity interest or otherwise control are accounted for as an investment in equity securities. We have elected to account for all investments in equity securities in accordance with the measurement alternative. Under the measurement alternative, we record the value of our investments in equity securities at cost, minus impairment, if any. Additionally, we adjust the carrying value of our investments in equity securities to fair value for observable transactions for identical or similar investments of the same issuer.

On April 24, 2023, we entered into a Subscription Agreement (the "April 2023 Subscription Agreement") with Heartland Dental Holding Corporation (“Heartland”). Pursuant to the Subscription Agreement we acquired less than a 5% equity interest through the purchase of Class A Common Stock for $75 million. We are not the primary beneficiary of nor are we able to
exercise significant influence over Heartland. As such, we are accounting for our investment in Heartland as an investment in equity securities.

Similar to our other investments in equity securities, Heartland is accounted for under the measurement alternative. Based on review of our investment in Heartland, we determined that no adjustments to the carrying value were necessary; therefore, it is properly reflected on our Condensed Consolidated Balance Sheet in Other assets at $75 million.

Investments in equity securities are reported on our Condensed Consolidated Balance Sheet as Other assets. We record upward and downward adjustments in carrying value or impairment, if any, in our investments in equity securities, in other income (expense), net in our Condensed Consolidated Statement of Operations. The carrying value of our investments in equity securities, exclusive of Heartland, were not material as of March 31, 2024 and the associated adjustments to the carrying values, if any, of the investments were not material during the three month periods ended March 31, 2024 and 2023.

Our investments in privately held companies in which we can exercise significant influence are accounted for as equity method investments. We have elected to account for our equity method investments under the fair value option. The carrying value of our equity method investments are reported on our Condensed Consolidated Balance Sheet as other assets and are not material as of March 31, 2024 and December 31, 2023.

Derivatives Not Designated as Hedging Instruments

We enter into foreign currency forward contracts to minimize the short-term impact of foreign currency exchange rate fluctuations on certain assets and liabilities. These forward contracts are classified within Level 2 of the fair value hierarchy. As a result of the settlement of foreign currency forward contracts, we recognized a net gain of $19.7 million during the three months ended March 31, 2024 and a net loss of $6.4 million during the three months ended March 31, 2023. Recognized gains and losses from the settlement of foreign currency forward contracts are recorded to Other income (expense), net in our Condensed Consolidated Statements of Operations. As of March 31, 2024 and December 31, 2023, the fair value of foreign exchange forward contracts outstanding were not material.
The following tables present the gross notional value of all our foreign exchange forward contracts outstanding as of March 31, 2024 and December 31, 2023 (in thousands):

March 31, 2024
Local Currency AmountNotional Contract Amount (USD)
Euro€262,300$283,818 
British Pound£121,800153,937 
Canadian DollarC$96,50071,174 
Polish ZlotyPLN276,400$69,117 
Chinese Yuan¥322,80044,536 
Japanese Yen¥4,300,00028,547 
Brazilian RealR$88,60017,650 
Mexican PesoM$270,00016,265 
Israeli ShekelILS48,200 13,137 
Swiss FrancCHF7,0007,776 
New Zealand DollarNZ$9,9005,912 
New Taiwan DollarNT$98,0003,064 
Australian DollarA$4,7003,061 
Czech KorunaKč44,6001,905 
Korean Won₩2,300,0001,708 
$721,607 

December 31, 2023
Local Currency AmountNotional Contract Amount (USD)
Euro€337,780$373,705 
Canadian DollarC$108,90082,166 
Polish ZlotyPLN276,90070,393 
British Pound£45,59058,005 
Chinese Yuan¥244,500.0034,361 
Swiss FrancCHF28,60034,132 
Japanese Yen¥3,577,00025,347 
Israeli ShekelILS78,70021,800 
Brazilian RealR$80,50016,563 
Mexican PesoM$230,000 13,593 
New Zealand DollarNZ$6,6004,161 
Australian DollarA$4,3002,921 
New Taiwan DollarNT$89,0002,919 
Czech KorunaKč60,2002,687 
Korean Won₩2,200,0001,709 
$744,462